PHARMACARIBE, LLC.
PUNTA GORDA, FLORIDA

PharmaCaribe, LLC is a global leader in the development, sourcing, and marketing of pharmaceutical and medical device products that offer added therapeutic benefits. Founded by W. Randolph Warner, a senior pharmaceutical development and regulatory pathway executive, and Werner Gutmann, former President and Chairman of the Board for PARI Respiratory Inc., PharmaCaribe specializes in innovative hypertonic saline solutions for inhalation. Established on October 23, 2007, the company is incorporated in Florida with its headquarters at 3513 DI LEUCA ST, Punta Gorda, FL. The founders' pioneering efforts led to FDA clearance of Hypertonic Saline in various concentrations (3%, 3.5%, 6%, 7%, and 10%) for therapeutic use beyond diagnostic purposes in 2010. This marked a significant milestone as PharmaCaribe became the first company to achieve such clearance, enhancing its reputation in the industry. In 2013, PharmaCaribe further distinguished itself by receiving FDA clearance for its bio-balanced™ second-generation saline solutions, reinforcing its commitment to improving patient outcomes and advancing inhalation therapies. The company's products, including PulmoSal and NebuSal, are manufactured to stringent USP standards and are available in formulations cleared for commerce. With a mission centered on enhancing the safety and efficacy of saline for inhalation, PharmaCaribe serves healthcare professionals, parents, and patients by improving respiratory health through cutting-edge solutions. The company's efforts are reflected in its comprehensive website (pharmacaribe.com) and ongoing research to inspire and educate stakeholders about the benefits of hypertonic saline. PharmaCaribe maintains a robust operational structure with W. Randolph Warner and Werner Gutmann serving as key managers, guiding the company under its status as an active entity per Florida's regulatory standards.